Analystreport

TrovaGene, Inc. (NASDAQ: TROV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

TROVAGENE  (TROV) 
Last trovagene earnings: 3/6 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: trovagene.com